Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation

About this update from Telescope Innovations Corp

[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M. Hawkins has expanded his consulting role with Telescope. Dr. Hawkins is an industry-wide authority in automating complex chemistry workflows and enabling the high-value kinetic and mechanistic datasets needed for chemical process development. His expertise will now support Telescope's expanding work in automated chemistry sampling technologies and autonomous, Self-Driving Laboratories.","length":755,"tagName":"p"},{"type":"text","content":"Dr. Hawkins has been a long-standing champion of applying automation, parallel experimentation, and data-rich process analytics to improve chemical development. His prior work with Pfizer and Technobis demonstrated how combining these technologies can accelerate the optimization of chemical processes in pharma R&D.","length":320,"tagName":"p"},{"type":"text","content":"Dr. Hawkins' deep domain knowledge in both chemistry and automation has already contributed to Telescope's lithium-sector process IP development, including advancements in its ReCRFT™ and DualPure™ technologies. While continuing his involvement in that area, Dr. Hawkins will also expand his role to join Telescope's development of:","length":344,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Automated reaction sampling technology, such as the DirectInject-LC™ platform, Telescope's flagship product line. He will also participate in the recently announced collaboration between Telescope and AGI to develop next-generation chemical reactors.","length":254,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Self-Driving Laboratories (SDLs), building on Telescope's deployment of these automated platforms at Pfizer and the Korean Pharmaceutical and Biopharma Manufacturer's Association. SDLs integrate robotics, inline analytics, and artificial intelligence to perform chemistry research faster and more efficiently than traditional methods.","length":342,"tagName":"p","attribs":{}}]}],"tagName":"ol","bulletedList":...

More updates from Telescope Innovations Corp